Development of a bioreactor based on magnetically stabilized fluidized bed for bioartificial liver

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Hepatology

Background:

• Bioartificial liver (BAL) devices aim to treat acute liver failure.
• Effective BALs require bioreactors with high flow rates and minimal void volume.
• Magnetically stabilized fluidized beds (MSFBs) offer potential advantages for microcapsule-based bioreactors.

Purpose of the Study:

• To develop a microcapsule-based MSFB bioreactor for bioartificial liver applications.
• To evaluate the performance and biocompatibility of the MSFB bioreactor.

Main Methods:

• Development of a microcapsule-based MSFB bioreactor.
• Comparison with conventional fluidized bed bioreactors.
• Assessment of perfusion velocity, void volume, mechanical stability, immunoisolation, and cell toxicity.

Main Results:

• The MSFB bioreactor significantly increased perfusion velocity and decreased void volume.
• Magnetite microcapsules maintained mechanical stability and immunoisolation during fluidization.
• Magnetite microcapsules exhibited no toxicity to cell survival.

Conclusions:

• The developed microcapsule-based MSFB bioreactor is a viable and effective design for bioartificial liver devices.
• This novel approach offers improved performance over conventional bioreactors.
• The MSFB bioreactor shows potential for advancing the treatment of acute liver failure.